Literature DB >> 20562640

Augmentation strategies in electroconvulsive therapy.

Colleen Loo1, Brett Simpson, Ross MacPherson.   

Abstract

Electroconvulsive therapy (ECT) is a highly effective treatment, but strategies to enhance therapeutic outcomes are occasionally needed. This review examines the evidence for approaches used for enhancing seizure production: hyperventilation, pretreatment with xanthines, and use of remifentanil or ketamine in ECT anesthesia. Hyperventilation may be a useful strategy to enhance seizure production, but its effects on ECT outcomes have not been systematically studied and require further research. Pretreatment with caffeine, theophylline or aminophylline (xanthines) prolongs the duration of ECT seizures but has not been clearly shown in controlled trials to increase efficacy. Caution is also warranted because their use may be associated with significant adverse effects. There are case reports of the usefulness of remifentanil in assisting seizure induction by reducing the dose of barbiturate anesthetic required, but there are no controlled data on whether it independently enhances efficacy outcomes. Preliminary evidence suggests that ketamine and ECT may have synergistic antidepressant effects, although this needs to be further examined in randomized controlled trials.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562640     DOI: 10.1097/YCT.0b013e3181e48143

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  15 in total

1.  Post-electroconvulsive therapy recovery and reorientation time with methohexital and ketamine: a randomized, longitudinal, crossover design trial.

Authors:  Tony Yen; Mohamad Khafaja; Nicholas Lam; James Crumbacher; Ronald Schrader; John Rask; Mary Billstrand; Jacob Rothfork; Christopher C Abbott
Journal:  J ECT       Date:  2015-03       Impact factor: 3.635

2.  Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study.

Authors:  Carolin Hoyer; Laura Kranaster; Christoph Janke; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-09       Impact factor: 5.270

3.  A novel Seizure Quality Index based on ictal parameters for optimizing clinical decision making in electroconvulsive therapy. Part 1: development.

Authors:  Laura Kranaster; Suna Su Aksay; Jan Malte Bumb; Carolin Hoyer; Christine Jennen-Steinmetz; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-06       Impact factor: 5.270

4.  Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study.

Authors:  Laura Kranaster; Jutta Kammerer-Ciernioch; Carolin Hoyer; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-13       Impact factor: 5.270

5.  Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.

Authors:  Chadi G Abdallah; Madonna Fasula; Ben Kelmendi; Gerard Sanacora; Robert Ostroff
Journal:  J ECT       Date:  2012-09       Impact factor: 3.635

6.  Effects of sevoflurane or ketamine on the QTc interval during electroconvulsive therapy.

Authors:  Feray Erdil; Zekine Begeç; Gülay Erdoğan Kayhan; Saim Yoloğlu; Mehmet Özcan Ersoy; Mahmut Durmuş
Journal:  J Anesth       Date:  2014-08-02       Impact factor: 2.078

Review 7.  The integrative role of the sigh in psychology, physiology, pathology, and neurobiology.

Authors:  Jan-Marino Ramirez
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

Review 8.  Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Yoshiteru Takekita; Taro Suwa; Naotaka Sunada; Hirotsugu Kawashima; Chiara Fabbri; Masaki Kato; Aran Tajika; Toshihiko Kinoshita; Toshi A Furukawa; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-01-28       Impact factor: 5.270

9.  Measurement of purine release with microelectrode biosensors.

Authors:  Nicholas Dale; Bruno G Frenguelli
Journal:  Purinergic Signal       Date:  2011-11-18       Impact factor: 3.765

Review 10.  Neuroplasticity and the next wave of antidepressant strategies.

Authors:  Shawn Hayley; Darcy Litteljohn
Journal:  Front Cell Neurosci       Date:  2013-11-20       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.